Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07579845 · ClinicalTrials.gov registry record · NA
Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress
A NA study, sponsored by OvationLab.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07579845 is a NA study that is actively recruiting participants, run by OvationLab. The registered enrollment target is 60 participants.
The verdict
NCT07579845, a NA study, is actively recruiting participants, sponsored by OvationLab.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.
Interventions
- DIETARY_SUPPLEMENT Humic and Fulvic Acid Dietary Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-05-05 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07579845
The ClinicalTrials.gov registry entry for NCT07579845 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OvationLab, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Humic and Fulvic Acid Dietary Supplement is the first listed.
NCT07579845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07579845 about?
NCT07579845 is a clinical study titled "Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress". The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.
What is the current status of trial NCT07579845?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-05-05. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07579845?
The interventions under investigation include: Humic and Fulvic Acid Dietary Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07579845?
This trial is sponsored by OvationLab, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.